Upgrade to SI Premium - Free Trial

FibroGen (FGEN) PT Lowered to $79 at Stifel

February 28, 2018 6:27 AM
Stifel lowered its price target on FibroGen (NASDAQ: FGEN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles